Latest Privium Fund Management B.V. Stock Portfolio

Privium Fund Management B.V. Performance:

2025 Q4: 0.24%YTD: 33.11%2024: 38.72%

Performance for 2025 Q4 is 0.24%, and YTD is 33.11%, and 2024 is 38.72%.

About Privium Fund Management B.V. and 13F Hedge Fund Stock Holdings

On 2026-02-03, the fund reported it's updated stock portfolio. In the 13F Holdings report, Privium Fund Management B.V. reported an equity portfolio of $543.1 Millions as of 31 Dec, 2025.

The top stock holdings of Privium Fund Management B.V. are TSLA, , . The fund has invested 18.9% of it's portfolio in TESLA INC and 12.2% of portfolio in SHOPIFY INC.

The fund managers got completely rid off ABIVAX SA, AVIDITY BIOSCIENCES INC (RNA) and ROIVANT SCIENCES LTD (ROIV) stocks. They significantly reduced their stock positions in ROCKET PHARMACEUTICALS INC (RCKT), SPROTT FDS TR and MERCK & CO INC (MRK). Privium Fund Management B.V. opened new stock positions in VIRIDIAN THERAPEUTICS INC (VRDN), ENGENE HOLDINGS INC and STOKE THERAPEUTICS INC (STOK). The fund showed a lot of confidence in some stocks as they added substantially to IREN LIMITED, VOYAGER THERAPEUTICS INC (VYGR) and SLB LIMITED (SLB).

Privium Fund Management B.V. Annual Return Estimates Vs S&P 500

Our best estimate is that Privium Fund Management B.V. made a return of 0.24% in the last quarter. In trailing 12 months, it's portfolio return was 33.11%.

Performance
S&P 500

New Buys

Ticker	$ Bought
viridian therapeutics inc	5,399,820
engene holdings inc	3,179,350
stoke therapeutics inc	1,745,700
cartesian therapeutics inc	1,243,720
sarepta therapeutics inc	925,360
nomad foods ltd	102,569

New stocks bought by Privium Fund Management B.V.

Additions

Ticker	% Inc.
iren limited	115
voyager therapeutics inc	111
slb limited	97.01
biontech se	75.26
lemonade inc	71.21
biogen inc	41.51
transocean ltd	36.87
ast spacemobile inc	31.82

Additions to existing portfolio by Privium Fund Management B.V.

Reductions

Ticker	% Reduced
rocket pharmaceuticals inc	-60.68
sprott fds tr	-52.77
seabridge gold inc	-50.99
merck & co inc	-43.17
spotify technology s a	-28.42
noble corp plc	-24.06
valaris ltd	-24.05
sandridge energy inc	-23.02

Privium Fund Management B.V. reduced stake in above stock

Sold off

Ticker	$ Sold
alx oncology hldgs inc	-931,578
roivant sciences ltd	-1,920,340
recursion pharmaceuticals in	-580,720
acadia pharmaceuticals inc	-1,502,340
avidity biosciences inc	-2,309,210
abivax sa	-2,581,980
sibanye stillwater ltd	-294,848
pan amern silver corp	-717,706

Privium Fund Management B.V. got rid off the above stocks

Sector Distribution

Privium Fund Management B.V. has about 29.1% of it's holdings in Others sector.

Sector	%
Others	29.1
Healthcare	25.7
Consumer Cyclical	24.1
Technology	13.6
Financial Services	6.5

Market Cap. Distribution

Privium Fund Management B.V. has about 44.2% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
MEGA-CAP	29.9
UNALLOCATED	29.2
LARGE-CAP	14.3
MID-CAP	13.7
SMALL-CAP	12.6

Stocks belong to which Index?

About 52.5% of the stocks held by Privium Fund Management B.V. either belong to S&P 500 or RUSSELL 2000 index.

Index	%
Others	47.6
S&P 500	33.8
RUSSELL 2000	18.7

Top 5 Winners (%)		%
WVE	wave life sciences ltd	115.3 %
ARWR	arrowhead pharmaceuticals in	85.1 %
TSHA	taysha gene therapies inc	58.4 %
ARQT	arcutis biotherapeutics inc	54.1 %
	lexeo therapeutics inc	49.5 %

Top 5 Winners ($)		$
ARWR	arrowhead pharmaceuticals in	13.9 M
	shopify inc	5.1 M
LMND	lemonade inc	3.5 M
AXSM	axsome therapeutics inc	3.4 M
IONS	ionis pharmaceuticals inc	3.4 M

Top 5 Losers (%)		%
QURE	uniqure nv	-58.1 %
ZLAB	zai lab ltd	-48.0 %
HIMS	hims & hers health inc	-42.8 %
COIN	coinbase global inc	-33.0 %
SE	sea ltd	-26.7 %

Top 5 Losers ($)		$
QURE	uniqure nv	-13.8 M
	spotify technology s a	-9.6 M
COIN	coinbase global inc	-8.8 M
SE	sea ltd	-7.6 M
RARE	ultragenyx pharmaceutical in	-2.3 M

Privium Fund Management B.V. Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Privium Fund Management B.V.

Privium Fund Management B.V. has 57 stocks in it's portfolio. About 68.2% of the portfolio is in top 10 stocks. QURE proved to be the most loss making stock for the portfolio. ARWR was the most profitable stock for Privium Fund Management B.V. last quarter.

Last Reported on: 03 Feb, 2026

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
ACAD	acadia pharmaceuticals inc	0.00	0.00	0.00	sold off	-100

ALXO	alx oncology hldgs inc	0.00	0.00	0.00	sold off	-100

AMD	advanced micro devices inc	2.37	60,000	12,849,600	unchanged	0.00

AMZN	amazon com inc	5.14	121,000	27,929,200	reduced	-18.79

ARQT	arcutis biotherapeutics inc	1.64	305,972	8,885,430	unchanged	0.00

ARWR	arrowhead pharmaceuticals in	4.87	398,204	26,436,800	reduced	-15.98

ASTS	ast spacemobile inc	1.94	145,000	10,531,400	added	31.82

AUTL	autolus therapeutics plc	0.12	326,245	649,228	added	5.64

AXSM	axsome therapeutics inc	1.91	56,878	10,388,200	added	7.86

BEAM	beam therapeutics inc	0.36	71,500	1,981,980	added	17.21

BIIB	biogen inc	2.38	73,480	12,931,700	added	41.51

COIN	coinbase global inc	3.29	79,000	17,865,100	unchanged	0.00

CRSP	crispr therapeutics ag	0.41	42,874	2,248,310	added	7.18

FATE	fate therapeutics inc	0.07	369,100	362,678	added	10.77

FDMT	4d molecular therapeutics in	0.29	210,000	1,575,000	added	6.35

HIMS	hims & hers health inc	0.24	40,000	1,298,800	unchanged	0.00

IONS	ionis pharmaceuticals inc	3.51	240,824	19,051,600	reduced	-3.24

KRYS	krystal biotech inc	0.55	12,170	3,000,390	unchanged	0.00

LMND	lemonade inc	3.25	248,259	17,671,100	added	71.21

MGTX	meiragtx hldgs plc	0.29	200,000	1,590,000	added	22.7